Literature DB >> 6572912

Identification of a cDNA clone for mouse apoprotein A-1 (apo A-1) and its use in characterization of apo A-1 mRNA expression in liver and small intestine.

J C Miller, R K Barth, P H Shaw, R W Elliott, N D Hastie.   

Abstract

A cDNA clone for mouse apoprotein A-1 (apo A-1), the major apoprotein of plasma high density lipoproteins, has been identified. In addition to structural and physiological evidence, a genetic polymorphism for mouse plasma apo A-1 has been used to confirm that this DNA sequence corresponds to the apo A-1 gene. Use of this clone in molecular hybridization studies has shown that the concentration of apo A-1 mRNA is similar in liver and small intestine and is constant along the entire length of the small intestine. We provide evidence that the same apo A-1 gene is expressed in both liver and small intestine. Apo A-1 mRNA is also present in the stomach and esophagus at 10-15% the concentration found in small intestine but is undetectable in other tissues (such as large intestine, pancreas, heart, kidney, spleen, and brain). Finally, we show that there is a differential effect of a diet high in saturated fat and cholesterol on apo A-1 mRNA levels in liver and small intestine.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6572912      PMCID: PMC393631          DOI: 10.1073/pnas.80.6.1511

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  The removal of cholesterol from aortic smooth muscle cells in culture and Landschutz ascites cells by fractions of human high-density apolipoprotein.

Authors:  Y Stein; M C Glangeaud; M Fainaru; O Stein
Journal:  Biochim Biophys Acta       Date:  1975-01-24

2.  Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin: cholesterol acyltransferase.

Authors:  A K Soutar; C W Garner; H N Baker; J T Sparrow; R L Jackson; A M Gotto; L C Smith
Journal:  Biochemistry       Date:  1975-07-15       Impact factor: 3.162

3.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

4.  Isolation of hen oviduct ovalbumin and rat live albumin polysomes by indirect immunoprecipitation.

Authors:  D J Shapiro; J M Taylor; G S McKnight; R Palacios; C Gonzalez; M L Kiely; R T Schimke
Journal:  J Biol Chem       Date:  1974-06-25       Impact factor: 5.157

5.  A protein cofactor of lecithin:cholesterol acyltransferase.

Authors:  C J Fielding; V G Shore; P E Fielding
Journal:  Biochem Biophys Res Commun       Date:  1972-02-25       Impact factor: 3.575

6.  Use of two-dimensional electrophoresis to identify and map new mouse genes.

Authors:  R W Elliott
Journal:  Genetics       Date:  1979-02       Impact factor: 4.562

7.  The removal of cholesterol from Landschütz ascites cells by high-density apolipoprotein.

Authors:  O Stein; Y Stein
Journal:  Biochim Biophys Acta       Date:  1973-11-29

8.  Multiple genes coding for the androgen-regulated major urinary proteins of the mouse.

Authors:  N D Hastie; W A Held; J J Toole
Journal:  Cell       Date:  1979-06       Impact factor: 41.582

9.  A comparative study on the removal of cellular lipids from Landschütz ascites cells by human plasma apolipoproteins.

Authors:  R L Jackson; A M Gotto; O Stein; Y Stein
Journal:  J Biol Chem       Date:  1975-09-25       Impact factor: 5.157

Review 10.  The plasma lecithins:cholesterol acyltransferase reaction.

Authors:  J A Glomset
Journal:  J Lipid Res       Date:  1968-03       Impact factor: 5.922

View more
  13 in total

1.  Apolipoprotein A-I inhibits experimental colitis and colitis-propelled carcinogenesis.

Authors:  K K Gkouskou; M Ioannou; G A Pavlopoulos; K Georgila; A Siganou; G Nikolaidis; D C Kanellis; S Moore; K A Papadakis; D Kardassis; I Iliopoulos; F A McDyer; E Drakos; A G Eliopoulos
Journal:  Oncogene       Date:  2015-08-17       Impact factor: 9.867

2.  Tissue-specific gene expression in mouse hepatocytes cultured in growth-restricting medium.

Authors:  T Spiegelberg; J O Bishop
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

3.  Developmental regulation of a gene that encodes a cysteine-rich intestinal protein and maps near the murine immunoglobulin heavy chain locus.

Authors:  E H Birkenmeier; J I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

4.  The full induction of human apoprotein A-I gene expression by the experimental nephrotic syndrome in transgenic mice depends on cis-acting elements in the proximal 256 base-pair promoter region and the trans-acting factor early growth response factor 1.

Authors:  M Zaiou; N Azrolan; T Hayek; H Wang; L Wu; M Haghpassand; B Cizman; M P Madaio; J Milbrandt; J B Marsh; J L Breslow; E A Fisher
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

Review 5.  High density lipoprotein, apolipoprotein A-I, and coronary artery disease.

Authors:  R A Srivastava; N Srivastava
Journal:  Mol Cell Biochem       Date:  2000-06       Impact factor: 3.396

6.  Expression of apolipoprotein A-I in rabbit carotid endothelium protects against atherosclerosis.

Authors:  Rowan Flynn; Kun Qian; Chongren Tang; Nagadhara Dronadula; Joshua M Buckler; Bo Jiang; Shan Wen; Helén L Dichek; David A Dichek
Journal:  Mol Ther       Date:  2011-07-19       Impact factor: 11.454

7.  Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses.

Authors:  E M Rubin; B Y Ishida; S M Clift; R M Krauss
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

8.  Synergistic interactions between transcription factors control expression of the apolipoprotein AI gene in liver cells.

Authors:  R L Widom; J A Ladias; S Kouidou; S K Karathanasis
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

9.  Dietary fat increases high density lipoprotein (HDL) levels both by increasing the transport rates and decreasing the fractional catabolic rates of HDL cholesterol ester and apolipoprotein (Apo) A-I. Presentation of a new animal model and mechanistic studies in human Apo A-I transgenic and control mice.

Authors:  T Hayek; Y Ito; N Azrolan; R B Verdery; K Aalto-Setälä; A Walsh; J L Breslow
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

10.  Different cis-acting DNA elements control expression of the human apolipoprotein AI gene in different cell types.

Authors:  K N Sastry; U Seedorf; S K Karathanasis
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.